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DiffusionAbstract Aim: To evaluate role of B-mode ultrasound, ultrasound elastography and DWI in
differentiating benign and malignant axillary lymph nodes.
Patients and methods: From July 2014 to July 2015, 30 patients with enlarged axillary nodes in
patients with malignant breast disease were examined by B mode ultrasound, US elastography
and DWI. Finally, ﬁndings of B-mode US, elastography and DWI were compared with patholog-
ical results (reference standard). ROC analysis was constructed to obtain best cutoff values for
B-mode criteria: elasticity score, strain ratio and ADC value.
Results: Mean SR of malignant nodes (8.26) was signiﬁcantly higher than that of benign nodes
(2.08) with P value <0.0001. Mean ADC value of malignant nodes (0.7) was signiﬁcantly lower
than mean ADC value of benign nodes (1.4) with P value <0.0001. Comparing results of three
imaging modalities showed that DWI had higher sensitivity and accuracy (100%, 96.4%, respec-
tively) than ultrasound elastography (88.89%, 93.33%, respectively) with both modalities which
had same speciﬁcity (91.67%). Also, DWI and US elastography had higher sensitivity, speciﬁcity,
accuracy than B-mode ultrasound (77.78%, 66.7%, 73.3% respectively).
Conclusion: DWI and US elastography signiﬁcantly aid in improving characterization of meta-
static axillary nodes than B-mode US, besides reducing unnecessary invasive biopsy.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Lymph nodes can become swollen and palpable from benign
causes such as sarcoidosis, infectious diseases and collagen vas-
cular diseases or from malignant causes including systemic
lymphoid dissemination of malignancy and lymphoma. Thus,
enlarged lymph nodes are often considered to be an important
sign of the above diseases (1).
Metastatic spread of tumor cells is responsible for the major-
ity of cancer deaths. Tumor cell dissemination is mediated by a
number of mechanisms, including local tissue invasion, lym-
phatic spread, hematogenous spread, or direct seeding of body
cavities or surfaces. Clinical and pathological observations
have strongly suggested that, for many tumors, the most com-
mon pathway of initial dissemination is via the lymphatics (2).
The most common malignant cause of abnormal axillary
lymph nodes is breast cancer (3). In addition, other primary
tumors can cause axillary lymph node metastases (e.g., malig-
nant melanoma, stomach, lung or ovarian carcinomas) (4).
Invasive methods such as ﬁne needle aspiration, biopsy or
excision of lymph nodes should be used for tissue characteriza-
tion, but, sample error, increased health care costs and possible
complications following the invasive procedures are common.
So, these invasive techniques are not widely accepted in the
work-up of patients with lymphadenopathy. A non-invasive
imaging technique, which is capable of reliable characteriza-
tion of suspected lymph nodes, will improve detection and
staging of malignant diseases and also play a signiﬁcant role
in therapy monitoring (5).
Ultrasound elastography is a method for visualizing the
elasticity characteristics of a lesion. On the basis that malignant
tissues tend to lose their elastic properties and become harder in
consistency, elastography has been used to examine several
organs, such as the liver, thyroid, prostate, and pancreas (6).
It has been reported to be helpful in the differential diagnosis
of metastasis in cervical and inguinal lymph nodes (7).
Because Real-time elastography combines the penetration
depth and resolution of ultrasound with high sensitivity to
stiffness contrast, it can detect the superﬁcial LNs, which elude
palpation due to their small size or their deep location within
the body (8). Both qualitative; Elasticity score (ES) and quan-
titative; strain ratio (SR) assessments are used for the interpre-
tation of real-time elastography (9).
Diffusion-weighted imaging (DWI) is a magnetic resonance
imaging (MRI) technique based on the imaging of the molec-
ular mobility of water. With DWI qualitative and quantitative
information about differences in diffusion capacities in benign
and malignant tissues can be obtained (10).
DWI enables the radiologist to move from morphological
to functional assessment of diseases. The axillary lymph nodes
are shown with marked high signal intensities in comparison
with the adjacent muscle and surrounding normal vessels on
DWI that makes it easy to identify (11).
Due to the different cellular density and extracellular diffu-
sion, metastatic lymph nodes may be distinguishable from nor-
mal lymph nodes with ADC measurements (12).
2. Aim of the work
The aim of this study was to prospectively evaluate the role of
B-mode ultrasound, Ultrasound elastography and Diffusion-weighted MRI in differentiating benign and malignant
enlarged axillary lymph nodes in patients with malignant
breast disease.
3. Patients and methods
3.1. Patients
This study was performed during the period from July 2014 to
July 2015 at Radiology Department, Mansoura University. It
included 30 patients: 29 females and 1 male. Their age ranged
from 36 to 57 years and mean age was 46.5 year. Inclusion cri-
terion was presence of enlarged axillary lymph nodes diag-
nosed by clinical examination and B mode ultrasound in
patients with malignant breast disease. In 30 patients 24 were
breast cancer patients and 6 patients had non Hodgkin lym-
phoma. Patients with history of previous operation or
chemo-radiotherapy on the breast or axilla and those with con-
traindications to MRI were excluded.
At ﬁrst, this study included 38 enlarged axillary lymph
nodes in 35 patients with malignant breast disease, and 8
lymph nodes were excluded for the following reasons: previous
chemotherapy and/or radiotherapy (n= 5), unsatisfactory
histopathological results (n= 2), and patient refusal to com-
plete the study (n= 1).
So, 30 patients with 30 lymph nodes were ﬁnally enrolled in
this study. The largest and most suspicious lymph node was
selected for analysis.
The study was approved by our institution’s ethics commit-
tee, and all patients gave informed consent before enrolled in
the study (see Figs. 1–5).
3.2. Methods
Conventional B mode ultrasound and real-time ultrasound
elastography were performed using Aplio XG system (Toshiba
Medical System, Tokyo, Japan) equipped with 6.2–12 MHz
linear array transducer.
DW MRI was performed by 1.5-T MR unit (Ingenia, Phi-
lips Medical Systems, the Netherlands) using a surface coil.
All the examinations were performed in succession by 2
independent radiologists (M.A. and M.S.). The ﬁrst radiologist
had 15 and 3 years experience in conventional ultrasound and
ultrasound elastography respectively and the second had 5 and
10 years experience in ultrasound elastography and MRI
examinations respectively. The 2 radiologists analyzed the
B-mode sonographic, elastographic and DW images by con-
sensus to eliminate reader variability. Both were blinded to
the ﬁnal pathologic results.
3.2.1. B-mode ultrasound and acquisition of the elastograms
First, conventional B-mode ultrasound images were obtained.
The patient was placed in the supine position, with her/his hand
behind her/his head so that, the arm is abducted and externally
rotated with elevation of affected arm and leaning to the other
side. Shape, size, cortical thickness and hilum state of each axil-
lary lymph node were evaluated and recorded as follows:
(1) Size was represented by transverse diameter (T) in
millimeter.
Fig. 1 Female patient 36 years old, presented with axillary swelling. Pathological examination revealed reactive (benign). (A) B-mode
ultrasound of the left breast shows enlarged axillary lymph node (16  7.7 mm) with oval shape and preserved hilum. (B) US elastogram
shows blue area less than 45%, given (score 2). (C) US elastography with Strain ratio (SR) measures 0.87. (D) MRI of the left axilla: DWI:
b 500 (left) and b 1000 (right) show hyperintense signal of the left axillary lymph node. (E) ADC map shows intermediate signal denoting
partially restricted diffusion. ADC value measured 1.58  103 mm2/s.
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Fig. 2 Female patient aged 40 years, presented with right axillary swelling. Pathological examination revealed reactive (benign). (A) B
mode ultrasound on right axilla shows enlarged axillary lymph node (22  7 mm) with oval shape and preserved hilum. (B) US elastogram
shows blue area more than 45%, given score 3. (C) US elastography with Strain ratio (SR) measures 1.02. (D) MRI of the right axilla:
DWI: b 500 (left) and b 1000 (right) show hyperintense signal of the right axillary lymph node. (E) ADC map shows persistence of high
signal that means free diffusion. ADC value measured 2  103 mm2/s.
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Fig. 3 Female patient aged 47 years, presented with right axillary mass. Pathological examination revealed metastatic invasive ductal
carcinoma (malignant). (A) B mode ultrasound on right axilla shows enlarged axillary lymph node 30  18 mm with irregular shape,
thickened cortex (13 mm) and compressed hilum. (B) US elastogram shows very small green area of the right axillary lymph node, given
elasticity score 4. (C) US elastography with Strain ratio (SR) measures 10.5. (D) MRI of the right axilla, DWI: b 500 (left) and b 1000
(right) show mixed hyperintense signal of the right axillary lymph node. (E) ADC map shows decreased signal of right axillary lymph node
(restricted diffusion). ADC value measured 0.7  103 mm2.
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Fig. 4 Male patient 57 years old, presented with right breast and axillary swelling. Pathological examination revealed metastatic invasive
ductal carcinoma (malignant). (A) B-mode ultrasound of right breast shows large solid malignant breast mass. (B) B-mode right axillary
ultrasound shows enlarged right axillary lymph nodes, the largest measures 24  17 mm with oval shape, lost hilum and foci of necrosis.
(C) US elastogram showed blue area more than 45%, given score 3. Foci of necrosis appeared green. (D) US elastography with strain ratio
(SR) measures 8.6. (E) MRI of the right breast and right axilla: DWI b 500 (left) and b 1000 (right) show hyperintense breast mass (arrow
head) and intermediate signal right axillary lymph node (arrow). (F) ADC map shows decreased signal of breast mass and axillary lymph
node denoting restricted diffusion, ADC value of the lymph node measured 0.6  103 mm2/s.
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diameter (L/T) ratio.
(3) Maximum cortical thickness was measured in
millimeter.(4) Hilum state was classiﬁed as preserved, compressed or
faint.
The B mode score proposed by (13) with slight modiﬁcation
was used to sum up the 4 criteria, as follows:
Fig. 4 (continued)
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>10 mm, score 1.
– Longitudinal to transverse diameter (L/T) ratio:>1.8, score
0; 61.8: score 1.
– Cortical thickness: 66 mm, score 0; >6 mm, score 1.
– Hilum: preserved, score 0; compressed or faint, score 1.
Then, the system was switched into elastography mode for
qualitative analysis of scoring method (color scale) and quan-
titative calculation of strain ratio to evaluate the stiffness of
the lymph node. Manual compression and decompression were
applied using the probe with only light pressure, perpendicular
to the skin. On average, 3 clips and 3 static images were
obtained per node for qualitative and quantitative assessment.
Elastogram appeared in the region of interest (ROI) to
determine the elasticity of the target lymph node and the sur-
rounding tissue. The enlarged node was represented by color
scale that ranged from red (softest component) to green (inter-
mediate stiffness) and blue (hardest component). Each lymph
node was given an elasticity score. In the qualitative evaluation
of the elastographic images, lymph node classiﬁcation was per-
formed on the basis of a 4-point scoring system proposed by
(13): score 1: absent or very small blue area, score 2: small,
scattered blue areas, total blue area <45%, score 3: large blue
area, total blue areaP45% and score 4: blue area all over the
node area with or without a green rim.
Strain ratio (semi-quantitative evaluation) was obtained by
comparing the absolute strain value of the lymph node cortex
with that of surrounding subcutaneous fat of highest strain.
The ﬁrst ROI (A) was placed in the subcutaneous fat of higheststrain at a depth similar or close to the depth of the lymph
node to avoid stress decay with the depth. The second ROI
(B) for the lymph node was placed in the blue area of the
lymph node cortex. The strain ratio was calculated automati-
cally by an embedded software program in the ultrasound unit.
3.2.2. MRI and DWI
Examination included image acquisition followed by image
post-processing.
A-Image acquisition (400–600 s): (1) axial and coronal
T2WI with TR: 3000, TE: 100, FOV: 360 mm, Slice thickness:
5 mm, Matrix: 256  256, (2) axial T2 spectral attenuated
inversion recovery (SPAIR) with TR: 1250, TE: 80, inversion
time 150 ms, FOV: 360 mm, slice thickness: 5 mm, Matrix:
256  256 and (3) DWI and ADC map, obtained by single
shot echoplanar image with TR: 900–1200, TE: 60 at b-values
of 0, 500, and 1000 s/mm2, FOV: 360 mm, slice thickness:
5 mm, Matrix: 256  256.
B-Image post-processing: Signal intensity in DW images
and ADC maps was recorded and ROIs were drawn manually
on the ADC map. ROIs were deﬁned as slightly smaller than
the actual nodes in order to reduce partial volume effects.
Mean ADC values were recorded. If multiple lymph nodes
were presented in the same axilla, the largest most suspicious
node selected by ultrasound was analyzed.
(1) Qualitative assessment: Visual assessment of signal
intensity in DW images at b 500 and 1000 and the corre-
sponding ADC map images was determined and classi-
ﬁed as follows: Free diffusion; high or intermediate SI
Fig. 5 Female patient 39 years old, presented with left axillary swellings. Pathological examination revealed Non-Hodgkin’s lymphoma.
(A) B-mode ultrasound: enlarged left axillary lymph nodes, the largest measures 30  18 mm with thickened cortex (13 mm) and
compressed hilum. (B) US elastogram shows blue area more than 45%, given score 3. (C) US elastography with SR measures 11.1 (D)
MRI of the left axilla: DWI b 500 (left) and b 1000 (right) show hyperintense signal of the left axillary lymph node. (E) ADC map shows
decreased signal intensity of the node denoting restricted diffusion, ADC measured 0.66  103 mm2/s.
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Table 1 Final diagnosis by pathological examination.
Diagnosis No Percentage (%)
Benign
– Reactive 8 26.7
– Non-speciﬁc lymphadenitis 4 13.3
Total 12 40
Malignant
– Non-Hodgkin’s lymphoma 6 20
– Invasive ductal carcinoma 12 40
Total 18 60
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ADC map, partially restricted; high or intermediate SI
on DWI with partial decrease or loss of SI on corre-
sponding ADC map and restricted; high or intermediate
SI on DWI with total decrease or loss of SI on the cor-
responding ADC map.
(2) Quantitative assessment: mean ADC value was calcu-
lated by manually drawing regions of interest (ROI) in
the most restricted (hypointense) portion of the selected
LN on the ADC map. Multiple measurements are
acquired and the mean value was calculated.
Finally, ﬁndings of B-mode ultrasound, elastography and
DWI were compared with pathological results (reference stan-
dard) either cytological by FNAC or histological by core nee-
dle, excisional biopsy or axillary dissection according to the
surgeon’s choice. In patients with benign enlarged axillary
lymph nodes, follow-up was done for 6–10 (average 8) months
to ensure its benign nature.
3.3. Statistical analysis
The statistical tool used for data analysis was the program
SPSS (Statistical package for social science) version 17.0. DataTable 2 Different B mode criteria (mean transverse diameter; mean
and hilum) and US elastography (different elasticity scores and mea
Parameter Benign N= 12
T (mm) Mean ± SD 10 ± 3.2
L/T ratio Mean ± SD 2.17 ± 0.6
Cortical thickness (mm)
Mean ± SD
5.83 ± 3.1
Hilum Benign %
N= 12
Preserved 8 66.7
Compressed 3 25
Faint 1 8.3
Elasticity score Benign %
(N= 12)
1 4 33.3
2 6 50
3 2 16.6
4 0 0
Strain ratio Benign
N= 12
Mean ± SD 2.08 ± 1.8were expressed as mean ± standard deviation (SD) for quanti-
tative parametric measures, in addition to median percentiles
for quantitative non-parametric measures and both number
and percentage for categorized data. For comparison between
two independent mean groups for parametric data, T test was
used, while, Chi-squared test was applied to study the associa-
tion between each two variables or comparison between two
independent groups as regards the categorized data.
The ﬁnal pathological diagnosis was used as the reference
standard. The probability of error (P value) at 0.05 was con-
sidered signiﬁcant, while, at 0.01 and 0.001 it was considered
highly signiﬁcant. In addition, the diagnostic validity test
was used to calculate the sensitivity, speciﬁcity, positive predic-
tive value, negative predictive value and diagnostic accuracy or
efﬁcacy. Alternatively, receiver operating characteristic (ROC)
analysis was constructed to obtain the best cutoff value for the
strain ratio and ADC value.
4. Results
Thirty patients with enlarged axillary lymph nodes were eval-
uated, 12 nodes were benign and 18 nodes were metastatic
(Table 1).
4.1. B-mode ultrasound criteria
Criteria of B mode ultrasound were classiﬁed into 4 main
points: transverse diameter (T), longitudinal to transverse
diameter ratio (L/T ratio), cortical thickness and state of
hilum.
The mean transverse diameter of malignant nodes
(16.22 mm) was signiﬁcantly higher than that of benign nodes
(10 mm) with P value = 0.0004, the mean L/T ratio of malig-
nant nodes was 1.84 while that of benign nodes was 2.17 with
insigniﬁcant P value = 0.14 and the mean cortical thickness of
malignant nodes (11.33 mm) was signiﬁcantly higher than thatlongitudinal to transverse diameter ratio; mean cortical thickness
n strain ratios) of benign and malignant axillary lymph nodes.
Malignant N= 18 P value
16.22 ± 5.3 0.0004
1.84 ± 0.6 0.1448
11.33 ± 5.98 0.0027
Malignant % P value
N= 18
2 11.1 0.006
14 77.8
2 11.1
Malignant %
(N= 18)
0 0
2 11.1
8 44.4
8 44.4
Malignant
N= 18
P value
8.26 ± 2.8 <0.0001
Table 3 Qualitative assessment by DWI (free, partially
restricted and restricted diffusion) and quantitative assessment
by mean ADC value in differentiating benign and malignant
axillary nodes.
DWI Benign
N= 12
% Malignant
N= 18
% P value
Free 8 66.7 0 0 0.0002
Partially
restricted
2 16.7 6 33.3
Restricted 2 16.7 12 66.7
ADC value Benign N= 12 Malignant N= 18 P value
Mean ± SD 1.4 ± 0.3 0.7 ± 0.16 <0.0001
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signiﬁcant difference in the state of hilum between benign and
malignant lymph nodes as 8 out of 12 benign nodes showed
preserved hilum while 14 out of 18 malignant nodes showed
compressed hilum and 2 malignant nodes had faint hilum (P
value = 0.006) (Table 2).
When a transverse diameter (T) > 10 mm was used as a
cutoff value, it resulted in 77.8% sensitivity, 66.7% speciﬁcity
and 73.3% accuracy in differentiation between benign and
malignant axillary nodes. An L/T ratio >1.8 was used as a
cutoff value, and the sensitivity, speciﬁcity, and accuracy were
77.8%, 75%, and 76.7% respectively. Cortical thickness
>6 mm showed 77.8% sensitivity, 66.7% speciﬁcity and accu-
racy of 73.3%. As compressed or faint hilum was used as a
sign of malignancy, sensitivity, speciﬁcity and accuracy were
88.9%, 66.7% and 80% respectively (Table 4).
Presence of more than two of the 4 B-mode ultrasound cri-
teria in a lymph node (summation score) resulted in 77.78%
sensitivity, 66.7% speciﬁcity and 73.3% accuracy in differenti-
ating benign and malignant axillary nodes (Table 4).
4.2. Ultrasound elastography
4.2.1. Qualitative assessment (elasticity score)
Four out of 12 benign nodes had elasticity score ‘‘1”, 6 benign
nodes had elasticity score ‘‘2”, 2 benign nodes had elasticity
score ‘‘3” and non benign nodes had score ‘‘4”. On the con-
trary, 8 out of 18 malignant nodes showed elasticity score
‘‘4”, 8 malignant nodes showed score ‘‘3”, 2 showed score
‘‘2” and non malignant nodes had score ‘‘1” (Table 2).
Using elasticity score >2 for characterization of malignant
nodes resulted in sensitivity, speciﬁcity and accuracy of
88.89%, 83.33% and 86.67% respectively (Table 5).Table 4 Cutoffs of B mode criteria, B-mode summation score and
Parameter Cutoﬀ AUC 95% CI Sensit
T >10 mm 0.829 0.681–0.976 77.8
L/T >1.8 0.685 0.475–0.895 77.8
Cortical thickness >6 mm 0.819 0.667–0.972 77.8
Hilum Compressed or faint 0.759 0.575–0.944 88.9
Total score >2 0.856 0.720–0.993 77.784.2.2. Quantitative assessment: strain ratio
Mean SR of malignant nodes (8.26) was signiﬁcantly higher
than that of benign nodes (2.08) with P value <0.0001
(Table 2).
When a SR > 2.4 was used as a cutoff value for differenti-
ation between benign and malignant axillary nodes, it resulted
in sensitivity of 88.89%, speciﬁcity of 91.67%, accuracy of
90%, PPV of 94.1% and NPV of 84.6% (Table 5).
Using combined ES > 2 and SR > 2.4 resulted in 88.89%
sensitivity, 91.67% speciﬁcity, 93.33% accuracy, 94.4% PPV
and 91.7% NPV for characterization of malignant nodes
(Table 5).
4.3. DWI & ADC maps
4.3.1. Qualitative assessment (DW images)
DW images were acquired at b values: 0, 500, 1000 s/mm2. Sig-
nal intensities of the lymph nodes were determined by correlat-
ing the signal in DW images and the corresponding ADC
maps. Lymph node with high signal intensity in DWI with
no attenuation in the corresponding ADC map was considered
free diffusion, while attenuation of signal intensity in the ADC
map is considered restricted diffusion either it occupies part of
the lymph node area (partially restricted diffusion) or all over
the node area (restricted diffusion).
On DWI, 8 out of 12 benign nodes showed free diffusion, 2
benign nodes showed partially restricted diffusion and 2
benign nodes showed restricted diffusion, while 12 out of 18
malignant nodes had restricted diffusion, 6 malignant nodes
had partially restricted and none of the malignant nodes had
free diffusion (Table 3).
When the partially restricted and restricted diffusion were
used as a marker of malignancy, the results were 100% sensi-
tivity, 66.67% speciﬁcity, 92.9% accuracy, 81.8% PPV and
100% NPV (Table 6).
4.3.2. Quantitative assessment (ADC value)
There was statistically signiﬁcant difference between mean
ADC value of malignant nodes (0.7) and mean ADC value
of benign nodes (1.4) with P value <0.0001 (Table 3).
An ADC cutoff value >1.0 showed sensitivity, speciﬁcity,
accuracy, PPV and NPV of 100%, 91.67%, 96.4%, 94.7%
and 100% respectively (Table 6).
Combined evaluation by both partially restricted or
restricted diffusion on DWI, ADC maps and an ADC value
>1.0 resulted in 100% sensitivity, 91.67% speciﬁcity, 96.4%
accuracy, 94.7% PPV and 100% NPV (Table 6).
Comparing the overall results of three imaging modalities
showed that DWI had higher sensitivity, accuracy, PPV and
NPV (100%, 96.4%, 94.7%, 100% respectively) than ultra-their diagnostic performance.
ivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
66.7 73.3 77.8 66.7
75 76.7 82.4 69.2
66.7 73.3 77.8 66.7
66.7 80 80 80
66.7 73.3 77.8 66.7
Table 5 Cutoff value of elasticity score, strain ratio and its diagnostic performance.
Parameter Cutoﬀ AUR 95% CI Sensitivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
ES >2 0.917 0.757–0.986 88.89 83.33 86.67 88.9 83.3
SR >2.4 0.954 0.853–1.000 88.89 91.67 90 94.1 84.6
Parameter Cutoﬀ Sensitivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
ES + SR ES > 2 and SR > 2.4 88.89 91.67 93.33 94.4 91.7
Table 6 Diagnostic performance of diffusion-weighted imaging (qualitative assessment, ADC cutoff value (quantitative) and
combined qualitative and quantitative assessment).
Parameter AUC 95% CI Sensitivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
DWI Partially restricted or restricted 0.833 0.694–0.973 100 66.67 92.9 81.8 100
ADC cutoﬀ >1.0 0.944 0.835–1.000 100 91.67 96.4 94.7 100
Parameter Cutoﬀ Sensitivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
DWI + ADC Partially restricted or restricted + ADC> 1.0 100 91.67 96.4 94.7 100
Table 7 Comparison between B-mode ultrasound, ultrasound elastography and diffusion-weighted imaging.
Parameter Sensitivity (%) Speciﬁcity (%) Accuracy (%) PPV (%) NPV (%)
B mode US 77.78 66.7 73.3 77.8 66.7
UE 88.89 91.67 93.33 94.4 91.7
DWI 100 91.67 96.4 94.7 100
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tively) with both modalities had the same speciﬁcity (91.67%).
Also, DWI and US elastography had higher sensitivity,
speciﬁcity, accuracy, PPV and NPV than B-mode ultrasound
(77.78%, 66.7%, 73.3%, 77.8% and 66.7% respectively)
(Table 7).
5. Discussion
Lymphatic metastasis is an important prognostic factor in
patients with cancer. Although lymph nodes can be detected
and visualized by several imaging modalities including ultra-
sound (US), computed tomography (CT) and magnetic reso-
nance imaging (MRI), the differentiation between benign
and malignant lymph nodes remains challenging (12).
The B mode ultrasound ﬁndings of enlarged axillary lymph
nodes were reported in a study (13). They found that mean
transverse diameter (T) of metastatic axillary lymph nodes
was signiﬁcantly larger than that of reactive axillary lymph
nodes (P value <0.001), and absence of the hilum and eccen-
tric cortical thickening were associated with metastatic lymph
nodes (P value = 0.004 and 0.012, respectively) and no differ-
ence was found in the mean longitudinal to transverse axis
diameter ratios (L/T) between reactive and metastatic lymph
nodes (P value = 0.286). In this study, the results are in agree-
ment with (13) as the mean T of malignant nodes (16.22
± 5.3 mm) was signiﬁcantly higher than that of benign nodes
(10 ± 3.2 mm) (P value = 0.004); the mean cortical thickness
in malignant nodes (11.33 ± 5.98 mm) was signiﬁcantly higherthan that of benign nodes (5.83 ± 3.1 mm) (P
value = 0.0027); compressed and faint hila were signiﬁcantly
associated with malignant nodes (P value = 0.006); and the
mean (L/T) ratio in malignant nodes (1.84 ± 0.6 mm) was
not signiﬁcantly different from its mean value in benign nodes
(2.17 ± 0.6 mm) (P value = 0.145).
Choi et al. (13) proposed a score for the summation of the 4
B-mode criteria: transverse diameter (<7.0 mm, score 0;
P7.0 mm, score 1), longitudinal to transverse diameter ratio
(>2.0, score 0; 62.0, score 1), hilum (present, score 0; absent,
score 1), and cortical thickening (thin or concentric thickening,
score 0; eccentric thickening or not available, score 1). The
score was signiﬁcantly higher in metastatic lymph nodes than
in reactive lymph nodes (P value <0.001). When the best B-
mode score cutoff >2 was used, the sensitivity, speciﬁcity,
accuracy, PPV and NPV, were 74.2%, 78.8%, 76.7%,
76.5%, and 76.6% respectively. In the current study, a modiﬁ-
cation was done for these criteria to increase the degree for sus-
picion of malignancy as follows: transverse axis (T) diameter
(610 mm, score 0; >10 mm, score 1), longitudinal to trans-
verse diameter (L/T) ratio (>1.8, score 0; 61.8, score 1), cor-
tical thickness (66 mm, score 0; >6 mm, score 1) and hilum
state (preserved, score 0; compressed or faint, score 1). When
score >2 was selected as cutoff for malignancy, the results
were similar to (13) with no signiﬁcant increase in sensitivity,
and it resulted in 77.8% sensitivity, 66.7% speciﬁcity, 73.3%
accuracy, 77.8% PPV and 66.7% NPV.
The elastographic results of the current study revealed that
16 out of 18 (88.8%) malignant nodes had score ‘‘3 or 4” and
10 out of 12 benign nodes (83.3%) had score ‘‘1 or 2”. The
1148 M.A. Latif et al.mean elasticity score (ES) in malignant nodes (3.33 ± 0.7) was
signiﬁcantly higher than that of benign nodes (1.83 ± 0.7) (P
value <0.0001). When ES > 2 used as a cutoff value for
malignancy, it resulted in 88.9% sensitivity, 73.3% speciﬁcity,
86.7% accuracy, 88.9% PPV and 83.3% NPV.
Many studies run in accordance with our results as (13)
found that 25 of 31 (80.6%) metastatic lymph nodes displayed
scores ‘‘3 and 4”, whereas, 22 of 33 (66.6%) reactive nodes
showed scores ‘‘1 and 2” and there was a signiﬁcant difference
in ES between reactive and metastatic axillary lymph nodes (P
value <0.001). The optimal cutoff for differentiating benign
and malignant nodes was Score >2 yielded sensitivity of
80.7%, speciﬁcity of 66.7%, accuracy of 73.4%, PPV of
69.4% and NPV of 78.6%. Also, Furukawa et al. (14) found
that scores 3 and 4 are only observed in malignant nodes, as
32 of 34 malignant nodes (94.1%) showed scores 3 and 4,
whereas scores 1 and 2 are encountered in all 11 benign nodes
and in 2 of 34 malignant nodes (5.9%). Score >2 as cutoff for
malignancy yielded 74.4% sensitivity and 97.1% speciﬁcity.
Alam et al. (15) suggested a ﬁve pattern scoring system. They
found that 44 of 53 (83%) metastatic nodes displayed pattern
3, 4 or 5. All reactive nodes displayed pattern 1 or 2. The cutoff
value (scoreP 3) yielded results of 83% Sensitivity, 100%
speciﬁcity and 89% accuracy. More recently, Ishibashi et al.
(16) found that 26 of 31 (83.9%) metastatic nodes showed
scoreP 3. A cutoff ESP 3 for malignancy resulted in
83.87% sensitivity, 82.50% speciﬁcity, 83.10% accuracy,
78.79% PPV and 86.80% NPV.
As regards the semi-quantitative assessment, strain ratio
(SR), in the current study, there was a signiﬁcant difference
in mean SR of malignant nodes (8.26 ± 2.8) and benign
ones(2.08 ± 1.8) (P< 0.001), and a cutoff value 2.4 yielded
Sensitivity of 88.9%, speciﬁcity of 91.7%, accuracy of 90%,
PPV of 94.1% and NPV of 84.6%. This is in agreement with
Choi et al. (13) who stated that mean SR for metastatic axil-
lary lymph nodes (7.1) was signiﬁcantly higher than the ratio
for reactive axillary lymph nodes (3.5); (P value = 0.007).
SR cutoff value of 2.3 resulted in sensitivity, speciﬁcity, PPV,
NPV, and accuracy of 82.8%, 56.3% 61.5%, 77.3%, and
67.2%, respectively. Also, Zhang et al. (17) found that SR of
malignant lymph nodes was higher than that of the benign
ones. The best SR cutoff point was 2.39, with 78.41% sensitiv-
ity and 98.51% speciﬁcity and AUC was 0.915.
The combined use of ES and SR resulted in increase in
accuracy for characterization of malignant axillary nodes, as
the results of the current study showed that combined use of
ES and SR had accuracy of 93.3%, and sensitivity, speciﬁcity,
PPV and NPV of 88.9%, 91.7%, 94.4% and 91.7% respec-
tively. Also, Choi et al. (13) found that combined evaluation
by ES and SR resulted in accuracy of 73.4%, and sensitivity,
speciﬁcity, PPV and NPV of 80.7%, 66.7%, 69.4% and
78.6% respectively.
However, in the study of Park et al. (18), there was no dif-
ference between the AUC of conventional ultrasound and the
AUC of the combination of conventional ultrasound and
ultrasound elastography (P= 0.16). They concluded that
added strain elastography does not improve the diagnostic
ability of conventional ultrasound when evaluating abnormal
axillary lymph nodes.
As regards the qualitative assessment of DWI, Scaranelo
et al. (19) found that the results obtained from depiction of
restriction based on visual analysis of DW images and ADCmaps showed a sensitivity of 84%, speciﬁcity of 77% and accu-
racy of 80% for differentiation of malignant and benign axil-
lary lymph nodes. This is in accordance with the results of
our study as partial or total restriction of diffusion in lymph
nodes was signiﬁcantly associated with malignancy (P
value = 0.0002) with 100% sensitivity, 66.7% speciﬁcity,
92.7% accuracy, 81.8% PPV and 100% NPV.
The quantitative assessment on ADC maps: in this study, the
ADC value in malignant nodes (0.7  103 mm2/s) was signif-
icantly lower than that in benign ones (1.4  103 mm2/s)
(P< 0.0001) with the best cutoff value for malignancy
>1.0  103 mm2/s resulted in sensitivity of 100%, speciﬁcity
of 91.7%, accuracy of 96.4%, PPV of 94.7%, and NPV of
100%.
The following studies found results similar to the results of
the current study:
Fornasa et al. (20) found that the ADC values measured in
the metastatic lymph nodes (0.87  103 mm2/s) were signiﬁ-
cantly lower than those of the benign nodes (1.49 
103 mm2/s) (P< 0.001). A cutoff value of 1.09  103 mm2/
s yielded a sensitivity of 94.7%, a speciﬁcity of 91.7%, an accu-
racy of 93.0%, a PPV of 90.0% and a NPV of 95.7%. Chung
et al. (21) found that the mean ADC value of the metastatic
axillary lymph nodes (0.69  103 mm2/s) was signiﬁcantly
lower than that of the benign nodes (1.04  103 mm2/s) (P
value <0.001). Their results showed 100% sensitivity, 83.3%
speciﬁcity, and 93.6% accuracy.
Luo et al. (22) concluded that the mean ADC value of
metastatic lymph nodes was signiﬁcantly lower than that of
benign lymph nodes (0.78  103 mm2/s versus
1.043  103 mm2/s) (P value <0.05). The cutoff ADC value
was at 0.89  103 mm2/s with 82.22% sensitivity, 82.35%
speciﬁcity, PPV 86.04%, NPV 77.78% and 82.28% accuracy.
Razek et al. (23) stated that there was statistically signiﬁcant
difference in mean ADC values between metastatic
(1.08  103 mm2/s) and benign (1.58  103 mm2/s) axillary
lymph nodes (P value = 0.001). The use of threshold ADC
value of 1.3  103 mm2/s for distinguishing metastatic from
benign axillary lymph nodes resulted in sensitivity of 93%,
speciﬁcity of 100%, accuracy of 95.6%, PPV of 100%, NPV
of 87.5% and AUC of 0.974.
To our knowledge there is no published study combined the
value of B-mode ultrasound, ultrasound elastography and
DWI in differentiating benign and malignant enlarged axillary
lymph nodes. Dawood et al. (24) is the only study to our
knowledge which discussed the value of combined ultrasound
elastography and diffusion weighted imaging in cervical lymph
node enlargement. They found that the sensitivity of ADC
value measurement (91.6%) was higher than that of elastogra-
phy (83.3%). The speciﬁcity of elastography (90%) was higher
than that of ADC value measurement (85%). The accuracy
rates of ADC value measurement and elastography were the
same (87.5%). Combined ADC value measurement and ultra-
sound elastography had the best results for detection of malig-
nant LNs (sensitivity of 91.6%, speciﬁcity of 95% and
accuracy of 93.8%).
In the current study, the sensitivity, speciﬁcity and accuracy
of DWI (100%, 91.67% and 96.4%) and US elastography
(88.89%, 91.67% and 93.33%) were higher than those of
B-mode ultrasound (77.78%, 66.7% and 73.3% respectively).
On comparing ultrasound elastography and DWI, sensitiv-
ity of DWI 100% was higher than sensitivity of ultrasound
B-mode ultrasound, sono-elastography and diffusion-weighted MRI 1149elastography (88.89%) while speciﬁcity of ultrasound elastog-
raphy was the same as DWI (91.67%). The accuracy of
DWI (96.4%) was slightly higher than that of ultrasound elas-
tography (93.33%).
5.2. Limitations
Limited number of patients was one important limitation.
Metastatic axillary lymph nodes were 18 (12 from breast
cancer and 6 were non Hodgkin lymphoma). Differentiation
of both categories was not done owing to the small number,
for future investigation with large sample size.
6. Conclusion
US elastography and DW MRI signiﬁcantly aid in improving
characterization and differentiation between benign and meta-
static axillary nodes, besides reducing the unnecessary invasive
biopsies.
DWI and US elastography had higher sensitivity, speciﬁcity
and accuracy than B-mode ultrasound. DWI had same speci-
ﬁcity, higher sensitivity, and slight higher accuracy than US
elastography in characterization of metastatic nodes. It is
advised to start using either one or both of them added to
the routine axillary imaging.
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